MULTIFOCAL BREAST CARCINOMA
Clinical trials for MULTIFOCAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for MULTIFOCAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial may spare thousands of breast cancer patients from chemo
Disease control OngoingThis large phase 3 trial studied over 5,000 women with hormone receptor-positive, HER2-negative breast cancer that had spread to 1-3 lymph nodes. Participants received standard hormone therapy (tamoxifen or an aromatase inhibitor) either alone or with chemotherapy. The goal was t…
Matched conditions: MULTIFOCAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
New combo aims to stop HER2+ breast cancer relapse
Disease control OngoingThis phase III trial tests whether adding tucatinib to standard T-DM1 therapy works better than T-DM1 alone at preventing breast cancer from coming back. It involves over 1,000 patients with HER2-positive breast cancer who still have cancer cells after initial treatment. The stud…
Matched conditions: MULTIFOCAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC